
Benzinga Pro data, Lineage Cell Therapeutics (AMEX:LCTX) reported Q4 sales of $1.20 million. Earnings fell to a loss of $29.19 million, resulting in a 272.61% decrease from last quarter. Lineage Cell Therapeutics collected $2.27 million in revenue during Q3, but reported earnings showed a $7.83 million loss.